MOLECULAR EVALUATION OF ANTISTAPHYLOCOCCAL SECONDARY METABOLITES OF BACTERIAL ISOLATES FROM HOSPITAL WASTEWATER ENVIRONMENT
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i6.17560Keywords:
Antibiotic resistance, Lantibiotics, Epidermin gene, Gram-positive bacteriaAbstract
Objective: Antibiotics revolutionized medicine in the 20th century, and have together with vaccination led to the near eradication of diseases such as tuberculosis in the developed world. Their effectiveness and easy access led to overuse, especially in livestock raising, prompting bacteria to develop resistance. The lantibiotics form a particular group among the antimicrobial peptides and are characterized by unique structural features. They are produced by a group of bacteria against some gram-positive bacteria. The present study was designed to screen for the lantibiotic producing organisms from the hospital samples.
Methods: The bacterial isolates were identified based on Bergey's manual of bacteriology and screened for the epidermin gene by polymerase chain reaction amplification.
Results: Of the 21 isolates screened, only 10 of them showed positive amplification for the epigene. Based on the biochemical characteristics, the isolates obtained were identified and labeled.
Conclusion: Further study on the purification of the compound need to be done. Some bacterial samples may not have the epidermin gene which does not show amplification, this confers that the epidermin gene is absent in certain organisms.
Downloads
References
Kaplan N, Albert M, Awrey D, Bardouniotis E, Berman J, Clarke T, et al. Mode of action, in vitro activity, and in vivo efficacy of AFN- 1252, a selective antistaphylococcal FabI inhibitor. Antimicrob Agents Chemother 2012;56:5865-74.
Karlowsk JA, Laing NM, Baudry T, Kaplan N, Vaughan D, Hoban DJ, et al. In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 2007;51:1580-1.
Francius G, Domenech O, Mingeot-Leclercq MP, Dufrêne YF. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin. J Bacteriol 2008;190(24):7904-9.
Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-b-boswellic acid from Boswellia serrate. BMC Microbiol 2011;11:54-67.
Ilić D, Damljanović I, Stevanović D, Vukićević M, Blagojević P, Radulović N, et al. Sulfur-containing ferrocenyl alcohols and oximes: New promising antistaphylococcal agents. Chem Biodivers 2012;9(10):2236-56.
Jørgensen NO, Brandt KK, Nybroe O, Hansen M. Delftia lacustris sp. Nov., A peptidoglycan degrading bacterium from fresh water, and emended description of Delftia tsuruhatensis as a peptidoglycan-degrading bacterium. Int J Syst Evol Microbiol 2009;59:2195-9.
Ackerley DF, Caradoc-Davies TT, Lamont IL. Substrate specificity of the nonribosomal peptide synthetase PvdD from Pseudomonas aeruginosa. J Bacteriol 2003;185(9):2848-55.
Sieber SA, Marahiel MA. Learning from nature’s drug factories: Nonribosomal synthesis of macrocyclic peptides. J Bacteriol 2003;185(24):7036-43.
Felnagle EA, Jackson EE, Chan YA, Podevels AM, Berti AD, McMahon MD, et al. Nonribosomal peptide synthetases involved in the production of medically relevant natural products. Mol Pharm 2008;5(2):191-211.
Ibrahima A, Yangb L, Johnstonc C, Liud X, Mab B, Magarvey NA. Dereplicating nonribosomal peptides using an informatics search algorithm for natural products (iSNAP) discovery. Proc Natl Acad Sci 2012;109(47):19196-201.
Bierbaum G, Sahl HG. Lantibiotics: Mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 2009;10(1):2-18.
Staunton J, Weissman KJ. Polyketide biosynthesis: A millennium review. Nat Prod Rep 2001;18(4):380-416.
Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J Antimicrob Chemother 2007;60(3):568-74.
Haste NM, Hughes CC, Tran DN, Fenical W, Jensen PR, Nizet V, et al. Pharmacological properties of the marine natural product marinopyrrole A against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011;55(7):3305-12.
Bordignon SE, Gatti DJ. Antagonistic activity of lactic acid bacteria isolated from artisan Italian salami. Braz J Food Technol Camp 2010;13(1):18-22.
Sathish SR, Kokati VB. In-vitro antimicrobial activity of marine actinobacteria against multidrug resistance Staphylococcus aureus. Asian Pac J Trop Biomed 2012;2(10):787-92.
Sheikh HM. Antimicrobial activity of certain bacteria and fungi isolated from soil mixed with human saliva against pathogenic microbes causing dermatological diseases. Saudi J Biol Sci 2010;17(4):331-9.
Wyatt MA, Lee J, Ahilan Y, Magarvey NA. Bioinformatic evaluation of the secondary metabolism of antistaphylococcal environmental bacterial isolates. Can J Microbiol 2013;59(7):465-71.
Thompson JM, Gündoğdu A, Stratton HM, Katouli M. Antibiotic resistant Staphylococcus aureus in hospital wastewaters and sewage treatment plants with special reference to methicillin-resistant Staphylococcus aureus (MRSA). J Appl Microbiol 2013;114(1):44-54.
Caboche S, Pupin M, Leclère V, Fontaine A, Jacques P, Kucherov G. NORINE: A database of nonribosomal peptides. Nucleic Acids Res. 2008;36:D326-31.
McLaughlin RE, Ferretti JJ, Hynes WL. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: Model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol Lett 1999;175:171-7.
Rajan V, Kumar VG, Gopal S. A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance. Indian J Med Res 2014;139(3):463-7.
Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 2011;134(5):704-8.
van de Kamp M, van den Hooven HW, Konings RN, Bierbaum G, Sahl HG, Kuipers OP, et al. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem 1995;230(2):587-600.
Piper C, Casey PG, Hill C, Cotter PD, Ross RP. The lantibiotic lacticin 3147 prevents systemic spread of Staphylococcus aureus in a murine infection model. Int J Microbiol 2012;2012:806230.
Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001;7(2):327-32.
Kruszewska D, Sahl HG, Bierbaum G, Pag U, Hynes SO, Ljungh A. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 2004;54(3):648-53.
Pyar H, Peh KK. Characterization and identification of Lactobacillus acidophilus using biolog rapid identification system. Int J Pharm Pharm Sci 2014;6(1):189-93.
Soni S, Soni UN. In-vitro anti-bacterial and anti-fungal activity of select essential oils. Int J Pharm Pharm Sci 2014;6(6):586-91.
Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T. Bacitracin and nisin resistance in Staphylococcus aureus: A novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol 2011;81(3):602-22.
Daly KM, Upton M, Sandiford SK, Draper LA, Wescombe PA, Jack RW, et al. Production of the BSA lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol 2010;192(4):1131-42.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
